Speaking on the development, Nilesh Gupta, managing director of Lupin, said, "The OTC segment is one of the fastest growing segments in the Indian pharmaceutical market. This, combined with our capabilities and expertise in this space, makes it a lucrative business opportunity for Lupin.
Read more: Lupin forays into OTC segment with Softovac